New joint replacement material developed at MGH put to first clinical useJuly 24, 2007New form of polyethylene will allow stronger, more versatile joint replacement Massachusetts General Hospital (MGH) surgeons have performed the first total hip replacement using a joint socket lined with a novel material invented at the MGH. An advance over first-generation highly crosslinked polyethylene, which was also developed at MGH and significantly reduced a serious complication of early hip implants, the new material may be applied in replacements for a wider variety of joints in a more diverse group of patients. "We think this material could be used for any joint in the body and in any implant design, even those demanding higher flexion and more mobility," says Orhun Muratoglu, PhD, co-director of the Harris Orthopædics Biomechanics and Biomaterials Laboratory (OBBL) at MGH, who developed the new material in collaboration with scientists at the Cambridge Polymer Group.
Total replacements for hips and other joints were developed in the late 1960s, but it soon became apparent that hip implants could start loosening about 5 years after surgery and would eventually fail completely. A team led by William Harris, MD, DSc, now director emeritus of the MGH OBBL, investigated this complication and found that long-term friction of the implant's head against the polyethylene-lined joint socket would break off small particles of polyethylene. The body's immune system reacted against these foreign particles, eventually destroying adjacent bone tissue and causing the implant to loosen - a condition called periprosthetic osteolysis. Harris and his colleagues, working with polymer chemists from MIT, found that high doses of radiation would "crosslink" the polyethylene, bonding molecules together to produce a much more durable material. The procedure also generates free radicals that could lead to oxidization and degradation of the implant, but the research team found that melting the material would eliminate free radicals. The first-generation highly crosslinked polyethylene was approved by the FDA for use in implants in 1999 and has been licensed to Zimmer, Inc. However, the MGH researchers knew that the first-generation material had limitations in strength that made it unsuitable for some types of joint replacement implants. Subsequently, Muratoglu found that oxidation could be blocked by diffusing the antioxidant vitamin E throughout the polyethylene material. Both mechanical testing and animal studies have shown that the new material resists wear as well as the first generation and is much stronger. Vitamin-E-stabilized, highly crosslinked polyethylene has also received FDA approval for use in joint implants and has been licensed to both Zimmer and to Biomet, Inc., which made the implant used in the first surgical procedure on July 16. "This material will allow us to offer our patients very long-term, high-performance joint replacements," says Andrew A. Freiberg, MD, chief of the Arthoplasty Service in the MGH Department of Orthopædics, who performed the first implant with the new material. "It should be suitable for higher-stress applications in younger patients, those who are more active and those who are heavier." Massachusetts General Hospital | |||||||||||||||||||||
|
Related Joint Replacement Current Events and Joint Replacement News Articles Hip resurfacing is not for everyone Hip resurfacing is often seen as a modern alternative to the more conventional total hip replacement, but new data from a study led by Rush University Medical Center suggest that a patient's age and gender are key to the operation's success. Study shows pine bark naturally reduces knee osteoarthritis According to the Center for Disease Control (CDC), osteoarthritis, the most common type of arthritis, is on the rise. A new study published in the August journal of Phytotherapy Research, reveals Pycnogenol, bark extract from the French maritime pine tree, reduced overall knee osteoarthritis (OA) symptoms by 20.9 percent and lowered pain by 40.3 percent. How often do hip and knee replacements need revision? A comprehensive study using nationwide data on hip and knee replacements in England has found that one in seventy-five patients require a revision of their joint replacement after three years. New test to diagnose osteoarthritis early A newly developed medical imaging technology may provide doctors with a long-awaited test for early diagnosis of osteoarthritis (OA), scientists from New York reported today at the 236th National Meeting of the American Chemical Society. Joint distraction promotes structural repair in patients with severe knee osteoarthritis oint distraction (the use of a surgical frame around a degenerated joint to strengthen and promote repair) promotes cartilage repair in severe end stage osteoarthritis (OA) of the knee, as demonstrated for the first time by data presented today at EULAR 2008, the Annual Congress of the European League Against Rheumatism in Paris, France. Research Examines Factors in Delaying or Declining Total Knee Replacement Surgery A study led by Dr. Ann F. Jacobson, associate professor in Kent State's College of Nursing, unveils the reasons why people may initially choose to postpone but ultimately undergo total knee replacement surgery and emphasizes the need for better patient education before and after the procedure. Study shows pine bark naturally reduces osteoarthritis More than 20 million Americans suffer from osteoarthritis, with half a million Americans having a total joint replacement each year. Are blood thinners post-op killers? New study shows that the use of powerful anticoagulants to prevent pulmonary embolism may actually lead to more deaths after surgery Young patients with knee disorder get active after new Stanford surgical procedure At 14 years old, Adam Vasser of Los Altos, Calif., was an active kid who loved baseball. Then a mysterious virus attacked his heart, making a heart transplant necessary to save his life. New Test for Joint Infection Could Spare Some Patients an Unnecessary Procedure A potential diagnostic test that could help surgeons confirm or rule out the presence of infection-causing bacteria in prosthetic joints that require surgical revision has been developed by researchers at the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a part of the National Institutes of Health (NIH). More Joint Replacement Current Events and Joint Replacement News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||